Podcasts about Precision

In this episode, we explore how the future of wellness is shifting away from endless optimization and toward a more personalized, less-is-more approach to health. We share our current favorite biohacks, discuss the benefits of an alcohol-free lifestyle, cycle syncing, peptides, and emerging technologies like the Ohm Lamp and stem cell therapies. We also unpack the growing backlash against "over-optimization" and why the next era of biohacking will prioritize precision, simplicity, and long-term resilience. Tune in for an inspiring conversation about aging well, supporting future generations, and why 2026 may be the most exciting time yet to take charge of your health.SHOW NOTES:0:40 Welcome to the podcast!2:15 Lauren's favorite biohack right now5:50 Foundational travel hacks6:40 Renee's rescue8:52 Renee's favorite biohack right now9:58 Benefits of no alcohol11:48 PhaseApp for cycle syncing15:31 The Ohm Lamp17:05 Revisiting peptides18:49 Comparison to microdosing23:29 RFK & new regulations24:43 Solving the problem of aging29:35 Excitement for the future of health32:15 Stem cells34:45 Supporting the senior population37:17 The era of ‘less' supplements44:35 Backlash trend of “over-optimization” 49:03 Major/minor signs on OURA50:33 Wellness centers53:26 Final advice & recap55:32 Thanks for tuning in!RESOURCES:Phase App - code: BIOHACKERBABESOhm Lamp - code: BIOHACKERBABESEllie MD PeptidesPeptide QuizEp 346: Addiction & Peptides with Samantha LanderEp 339: GLP-1 Dosing with Jay CampbellBiolongevity Labs - Discount code: BIOHACKERBABESEp 331: GP1 Biology & Calacurb with Sarah KennedyCalocurb - Discount code: RENEE10Dr. Vincent GiampapaBeam Minerals - Discount code: BIOHACKERBABES for 20% offKion Essential Amino Acids - Discount code: BIOBABES for 15% offEp 349: Airway Health & Snoring with Dr. Gene SambataroSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Lung cancer biopsies are still being done blind more often than you'd think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsies: a lack of imaging guidance that can lead to significant diagnostic errors. Early clinical pilots across multiple sites are demonstrating strong performance, with one hospital already converting into a paying customer. Looking ahead, the company is partnering with Stanford Medicine to develop AI-driven decision support tools to further improve diagnostic accuracy. Tune in to learn how next-generation imaging and AI are changing that reality and helping physicians hit the right target the first time! Resources: Connect with and follow Reza Khorasaninejad on LinkedIn.Follow LEADOPTIK on LinkedIn and explore their website!

Guest: Carrie Freeman Title: CEO, Eden Radioisotopes Company: Eden Radioisotopes, LLC LinkedIn: https://www.linkedin.com/in/carrie-freeman/ Episode Overview In this episode, we sit down with Carrie Freeman, CEO of Eden Radioisotopes, to explore the intersection of deep science, commercialization, and leadership. After spending 15 years at Intel and serving as a multi-time CEO, Carrie has built a career around transforming breakthrough technologies into scalable businesses. We discuss what it takes to commercialize innovations emerging from national laboratories, the resurgence of the nuclear industry, and why private capital is increasingly driving the next generation of nuclear technologies. Carrie also shares her perspective on leadership transitions, fundraising for long-horizon ventures, and how organizations can remain focused on human impact while operating at the cutting edge of science. Topics Covered Lessons learned from a 15-year career at Intel and their application to nuclear science Leading established organizations through executive transitions Commercializing technologies developed inside national laboratories The current state of the nuclear industry and emerging market opportunities Turning regulatory complexity into a sustainable competitive advantage Building and positioning a company that spans healthcare, energy, and security markets Communicating transformational opportunities to investors without losing credibility Differences between Family Office, Venture Capital, and Private Equity investors Managing investor expectations through long commercialization timelines Creating a mission-driven culture around "Precision Science, Human Impact" Key Discussion Points From Semiconductors to Nuclear Science Carrie reflects on the most important lessons learned during her tenure at Intel and explains how principles of operational excellence, precision, and scalability transfer directly into the highly regulated nuclear industry. Leading on Day One As a multi-time CEO, Carrie shares her framework for entering an organization, building trust quickly, assessing priorities, and establishing momentum without disrupting existing strengths. Commercializing Deep Technology Moving a breakthrough technology from a national laboratory into the private sector presents unique challenges. Carrie discusses the critical steps required to bridge the gap between scientific innovation and market adoption. The Nuclear Renaissance The conversation explores why nuclear technologies are experiencing renewed interest and how private-sector companies are accelerating innovation across healthcare, energy, and national security applications. Regulation as a Competitive Advantage Rather than viewing regulation solely as a barrier, Carrie explains how companies can leverage regulatory expertise to create durable competitive moats and strengthen market positioning. Raising Capital for Long-Term Innovation Deep-tech ventures often require patient capital and extended development timelines. Carrie shares insights on communicating vision, maintaining investor confidence, and aligning expectations for long-term value creation. Building Mission-Driven Teams With the company tagline "Precision Science, Human Impact," Carrie discusses how leaders can keep teams connected to the real-world impact of their work while navigating complex scientific and technical challenges. About Carrie Freeman Carrie Freeman is the CEO of Eden Radioisotopes and an experienced technology executive with leadership experience spanning semiconductors, advanced manufacturing, and nuclear science. Her career includes 15 years at Intel and multiple CEO roles focused on commercializing breakthrough technologies and scaling innovation-driven organizations. About Eden Radioisotopes Eden Radioisotopes develops advanced nuclear technologies that support applications across healthcare, energy, and security. The company's mission is captured in its guiding principle: "Precision Science. Human Impact." Learn more: https://edenrad.com/ Connect with Carrie Freeman LinkedIn: https://www.linkedin.com/in/carrie-freeman/ Disclaimer: The views expressed in this podcast are for informational purposes only. They do not constitute financial or legal advice, nor do they necessarily reflect the views of Finalis Inc. or Finalis Securities LLC, Member FINRA/SIPC. #Podcast #BusinessPodcast #CEO #FounderJourney #NuclearIndustry #NuclearEnergy #NuclearInnovation #Radioisotopes #DeepTech #Commercialization #TechnologyTransfer #NuclearMedicine #EnergyInnovation #AdvancedManufacturing

Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies redefining the landscape, how do you choose the right therapy for each unique patient? In this exclusive preview, Ashley Chen, PharmD, BCOP (Fred Hutchinson Cancer Center), shares actionable insights on:

In this episode, Jamie Dodson announces the launch of Wolf Precision's new Custom Rifle Build Kits and explains why they may be the future of the custom rifle industry. Learn how our Level 1 Build Kits allow shooters to own, build, maintain, and upgrade a world-class custom rifle while saving money and gaining valuable skills. Jamie dives into the advantages of component selection, quality control, rifle assembly, bedding, magazine fitting, and how the patented ACE System is changing the way custom rifles are built. Plus, hear about our new Rifle Building Classes, Wolf Pack online training, and how you can build and maintain your own custom rifle with confidence. Whether you're a hunter, competitor, or long-range enthusiast, this episode will show you how custom rifles are becoming more accessible than ever before. Learn more at: https://www.wolfprecision.net Sponsors MDT Chassis Systems - Learn more at: mdttac.com Krieger Barrels - Visit: kriegerbarrels.com Wolf Precision Training Opportunities • Long Range Shooting School Limited openings remaining for the 2026 season. • The Wolf Pack – Online Training Membership Includes the Online Long Range Shooting School, Reloading Class, and Prosumer Gunsmithing School for just $49/month.Members also receive 10% off Wolf Precision products and services, including ACE systems and barrel work. Learn more at: https://www.wolfprecision.net

After Farming Minister Angela Eagle's reshuffling out of DEFRA, we hear why the farming industry really doesn't like ministerial churn.We're looking at Scottish agricultural policy all week. There's a debate around whether land that's used for grazing, rather than growing other crops, should be targeted to produce more environmental benefits.Precision farming techniques and automation are getting more popular as a way to help reduce costs, but they depend on good connectivity. Something that can be a challenge in rural areas.Presented by Caz Graham and produced by Beatrice Fenton.

In this episode of Partner Perspectives, a special miniseries within the Look Forward podcast, host Molly Mintz explores the rapid evolution and enduring resilience of global fixed income markets. Drawing on S&P Global and Vanguard's joint research, Partner Perspectives: Unlocking Potential Ahead, the conversation examines how geopolitical disruption, technological innovation, and  new market innovations and infrastructure are transforming the bond market for issuers, investors, and portfolio managers alike.  Alexandre Birry of S&P Global Ratings provides the macro-credit perspective, explaining that bond markets have remained orderly and functional despite geopolitical uncertainty, energy price volatility, and broader macro risks. He discusses the surge in tech and AI-related issuance, the growing importance of selectivity in credit markets, and the longer-term potential of infrastructure innovations such as tokenization, DeFi, stablecoins, and digital settlement rails.  Matt Chessum of S&P Global Market Intelligence unpacks the growth of global fixed income ETFs, which have expanded into a multi-trillion-dollar market by offering investors diversified bond exposure through a single tradable vehicle. Chessum explains how bond ETFs can improve accessibility, transparency, and price discovery (especially during periods of stress), while also pointing to a future in which digitalization and tokenized market infrastructure further enhance market liquidity and flexibility.  Jeffrey Johnson of Vanguard takes listeners inside the mechanics of bond index fund management, explaining why fixed income indexing is far more complex than it may first appear. With benchmarks like the Bloomberg U.S. Aggregate Bond Index containing roughly 14,000securities, Johnson describes the "art and science" of sampling, risk alignment, trading, and cost management required to closely track a benchmark. He emphasizes why low-cost bond index funds remain a critical source of diversification and ballast in uncertain markets.  Chapters:  [00:00] - Introduction to Partner Perspectives and the evolution of fixed income  [03:00] - Alex Birry on bond market resilience amid geopolitical uncertainty  [05:25] - Tech issuance, AI disruption, and the new status quo in credit risk  [07:50] - The future of bond market infrastructure: DeFi, stablecoins, and tokenization  [10:45] - Matt Chesham on how fixed income ETFs work and why they've grown so quickly  [13:20] - Structural cost advantages, diversification, and the appeal of bond ETFs  [16:00] - How bond ETFs improve liquidity, price discovery, and market access  [20:10] - ETFs in volatile markets: resilience, stress scenarios, and risk transfer  [24:10] - Looking ahead: digitalization, modular bond investing, and market evolution  [29:45] - Jeffrey Johnson on the complexity of managing bond index funds  [31:45] - Why fixed income indexing lagged equities and what's driving adoption now  [35:10] - How investors use broad and targeted bond index funds  [37:10] - The "art and science" of tracking the Bloomberg US Aggregate Bond Index  [41:20] - Why active decision-making powers passive bond portfolios  [43:20] - Why bonds remain essential as portfolio ballast in uncertain times  [45:00] - Final takeaways and the importance of collaboration across markets  This podcast was authored by a cross-section of representatives from S&P Global and in certain circumstances external guest authors. The views expressed are those of the authors and do not necessarily reflect the views or positions of any entities they represent and are not necessarily reflected in the products and services those entities offer. This research is a publication of S&P Global and does not comment on current or future credit ratings or credit rating methodologies. 

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a rapidly evolving landscape marked by significant scientific breakthroughs, regulatory shifts, and strategic business maneuvers. The pharmaceutical and biotech sectors are buzzing with renewed vigor, as evidenced by an impressive resurgence in mergers and acquisitions. A recent analysis by PwC reports that M&A activity has reached over $65 billion in deal value during the first quarter of 2026, marking the strongest quarter since 2020. This uptick underscores a robust confidence within the industry, with companies strategically leveraging these mergers to bolster their pipelines and explore new therapeutic territories. Eli Lilly's acquisition of non-opioid pain drugmaker 4E is a case in point, as it reflects a broader industry shift towards precision medicine and non-opioid pain management solutions—a response to growing concerns over opioid addiction. On the regulatory front, notable developments include Colorado's drug import plan receiving FDA approval. This marks a bold step in curbing drug costs across the U.S., although implementation challenges remain due to complex logistical and regulatory landscapes. Meanwhile, Novo Nordisk is expanding its global manufacturing footprint with a new plant in the Czech Republic for diabetes and obesity drugs, alongside a $29 million investment to upgrade its Chinese facility. This expansion aligns with Novo's strategic preparation to seek Chinese regulatory approval for its Wegovy pill, potentially transforming the obesity treatment landscape. In a move that could reshape vaccine development, Moderna is advancing its mRNA-based influenza vaccine candidate through regulatory channels. The FDA's favorable reviews ahead of an advisory committee meeting highlight the growing acceptance of mRNA technology beyond COVID-19 vaccines. This technology holds promise for transforming vaccine development across various infectious diseases. Precision oncology continues to grapple with translating scientific discoveries into practical applications that genuinely improve patient outcomes. The ASCO 2026 conference emphasized this critical transition from discovery to implementation as essential for advancing precision medicine. Turning to gene therapy, UniQure is preparing for a significant milestone—submitting an accelerated Biologics License Application for its Huntington's disease therapy. This follows a reversal by the FDA, which now considers UniQure's Phase 1/2 trial data sufficient for submission. Should this therapy gain approval, it would be groundbreaking as the first genetic medicine for Huntington's disease, setting a precedent for future gene therapies targeting other genetic disorders. In another strategic partnership, Jazz Pharmaceuticals has teamed up with AbCellera to develop T-cell-engaging antibodies for oncology indications, illustrating the potential financial rewards associated with innovative cancer therapies. This collaboration could yield up to $820 million per program and highlights how partnerships are crucial in expediting drug development timelines. These stories reflect broader industry trends emphasizing innovation and strategic partnerships while navigating complex regulatory landscapes. The focus on precision medicine and advanced biologics continues to drive scientific advancements, with companies like Vedana Therapeutics targeting unmet needs in neurology through novel therapeutic approaches. Meanwhile, international collaboration is gaining traction in regulatory processes. The newly launched transatlantic liaison program between the FDA and MHRA aims to accelerate drug approvals and foster innovation across borders—an initiative that underscores the importance of collaborative frameworks. However, not all news is optimistic. Be Biopharma's decision to terminate its hemophilia B cell therapy trial highlights the challenges companies face in competitive therapeutic areas. Despite previous optimism, similar withdrawals by Pfizer and BioMarin indicate the necessity for robust clinical data and clear market differentiation strategies. Furthermore, Merck's recent agreement with Protillion Technologies marks an increased focus on integrating artificial intelligence into drug discovery processes—a trend promising accelerated timelines and improved trial success rates. As these developments unfold, it's evident that the pharmaceutical and biotech sectors are at an intersection where scientific innovation meets strategic business decisions. The potential approval of UniQure's gene therapy could catalyze further advancements in genetic medicine—while M&A activities suggest an industry poised for transformative growth. For stakeholders—from researchers to executives—the ability to adapt to these dynamic changes will be crucial in shaping the future of drug development and patient care. In conclusion, these stories collectively paint a picture of an industry evolving through scientific breakthroughs while adapting through strategic business decisions. As new technologies integrate into this space alongside regulatory advancements in gene therapy, this period of transformation holds promising implications for addressing unmet medical needs and enhancing therapeutic outcomes globally.Support the show

The Rebbe addresses concerns about praying in a consistent minyan with one's own nusach and whether to change locations for shofar blowing precision. He explains the spiritual importance of one's place and advises remaining, while also encouraging study of Rosh Hashanah discourses. https://www.torahrecordings.com/rebbe/igroskodesh/007/011/2211

Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu

AI precision marketing is reshaping how local businesses compete—through hyper-targeted campaigns, real-time monitoring, and Generative Engine Optimization strategies that put businesses in front of the right audiences at the right time. To learn more, visit https://www.bluoceantsunami.com/ Blu Ocean Innovations, LLC City: Las Vegas Address: 5940 South Rainbow Boulevard #400 7820 Website: https://bluoceaninnovations.ai

One month after Loryn and Edo Nalic opened Balkan Treatbox in 2019, I had the privilege of sitting down with Loryn and getting her take on the success of the restaurant. Now Loryn is a culinary superstar being recently crowned the James Beard Best Chef Midwest. She takes us on a delightful journey through her culinary roots and the evolution of her restaurant, Balkan Treatbox. From her childhood memories of cooking with family to the whirlwind of opening a food truck and now a full-fledged restaurant, Loryn shares the ups and downs of her culinary career. She recounts the transformative moments that shaped her passion for food, like her early days busing tables and her leap into pastry chef roles. We get into the intricacies of running a food truck, the challenges of sourcing ingredients, and the creativity that fuels her menu, which is inspired by the rich flavors of the Balkan region.As we celebrate her recent accolades, we also reflect on how community support and a team effort has been vital to her success, emphasizing the collaborative spirit among local chefs in St. Louis. Loryn and Arnold explore the vibrant food scene in St. Louis, highlighting how the city is gaining recognition on a national scale. They discuss the camaraderie among local chefs and how this interconnectedness strengthens the culinary landscape.Loryn's anecdotes about her experiences, from baking bread in a food truck to managing the demands of a bustling restaurant are engaging and give us a behind the scenes view. Listeners get a taste of the mouthwatering dishes served at Balkan Treatbox, like the beloved wood-fired bread and the unique flavors of cevapi, and how every dish tells a story. This conversation is not just about food; it's about passion, perseverance, and the joy of bringing people together through delicious meals.[00:00] Meet Loryn Nalic[00:13] Early Food Roots[00:55] Pastry Breakthrough[01:46] From Sysco to Pappy's[03:21] Launching the Truck[04:49] Food Truck Reality[08:35] From Truck to Restaurant[09:16] Balkan Menu Tour[12:19] Design and Identity[15:12] Opening Challenges[18:47] Lunch Only Growth[23:03] Precision and Pastry[24:10] St Louis Food Community[27:37] How to Visit and Follow[28:47] What is Next and FarewellTakeaways:Loryn Nalic's journey from culinary dreams to James Beard Best Chef accolade is truly inspiring!Building a food truck is not just grilling and cash registers, it's a complex culinary adventure!The St. Louis food scene is thriving, with chefs supporting each other like one big happy family!Every dish served is crafted with love, using fresh ingredients and traditional Balkan recipes!Transitioning from a food truck to a full-fledged restaurant has its challenges, but the rewards are worth it!Social media is the lifeblood of food trucks – it's how they keep their hungry fans in the loop!Balkan Treat Box - St. LouisInstagram - Balkan TreatboxFacebook - Balkan TreatboxThis is Season 9! For more episodes, go to stlintune.com#balkantreatbox #jamesbeardaward #stlouisfood #foodtrucks #balkanfood #streetfood #balkancuisine #woodfiredcooking #handmadebread

What if your next big business breakthrough started with owning your own blind spots?This Fan Favorite episode throws you in the trenches with Cameron Herold and SaaS Academy's former COO and current CEO Matt Verlachi, as they go far beyond surface-level business banter. From surviving firefighting chaos to building, selling, and now scaling SaaS Academy, Matt Verlachi exposes the real skills that make or break Second in Commands. They unpack why customer obsession cures more growth headaches than any software, how to weaponize one-on-ones for radical team development, and what most COOs get dead wrong about CEO dynamics.Miss this? You risk coasting on old habits while others engineer unfair advantages. Listen now for hard-won tactics you won't find in any business course from the world's largest SaaS coaching engine. Timestamped Highlights00:45 – The firefighting mindset that built decisive business instincts05:56 – The overlooked power of “small unit” teams to unlock real growth09:44 – Are you a COO trapped in a CEO's title? The unexpected identity test13:43 – Brutal truths about customer obsession and why most leaders fail here16:18 – The lesson no founder learns soon enough when selling their company18:22 – The surprising reason joining SaaS Academy changed his life21:31 – The founder's hidden block: How self-worth destroys pricing27:31 – The counterintuitive leadership split that 10x'd their decision speed41:07 – How his “full-person” one-on-ones rip open performance breakthroughs About the GuestMatt Verlaque was the former COO of SaaS Academy (now Precision), steering operational strategy for the largest coaching platform serving B2B SaaS entrepreneurs. With first-hand experience ranging from firefighting to founding and selling a SaaS startup, he delivers operating wisdom forged under real pressure. He is currently serving as the CEO at Precision, where they help growth-minded founders understand how their business actually works so they can scale with clarity, not chaos.

On Episode 282 of The Geoholics, we sit down with Tom Yeshurun, CEO of Civ Robotics, to explore how automation is transforming construction layout—and what that evolution means for surveyors, contractors, field crews, and the future of the geospatial profession. Tom shares the real-world frustrations that inspired Civ Robotics, the company's bold pivot from drones to ground-based robots, and the challenges of earning trust in an industry where accuracy, accountability, and boots-on-the-ground experience still matter. We dig into the line between surveying and construction layout, the productivity and profitability unlocked by robotic point placement, and why automation should elevate field professionals rather than simply replace them. We also look ahead to the fully connected jobsite—where robotics, machine control, digital twins, and human expertise converge—and discuss the skills today's young surveyors and geomatics professionals will need to remain valuable in an increasingly automated world. Precision gets you started. Automation makes you faster. Verification keeps you out of court. Music by Led Zeppelin #TheGeoholics #CivRobotics #TomYeshurun #ConstructionRobotics #RoboticLayout #ConstructionTechnology #ConTech #LandSurveying #Surveying #Geomatics #Geospatial #ConstructionLayout #Automation #DigitalTwins #MachineControl #FieldTechnology #RealityCapture #FutureOfConstruction #Innovation #Surveyors #AECIndustry #BuiltEnvironment #LeicaGeosystems #Emlid #TopoDOT #AllTerraCentral #AddingValueAndMakingFriends

Jonathan Jayarajan, Steve Powers, Tom Sykes and Mitch Collett discuss the key challenges and opportunities facing the Consumer Staples industry.

In this Corn Special Series episode of The Crop Science Podcast Show, Dr. Kevin Bradley, Professor and State Extension Weed Scientist at the University of Missouri, discusses practical strategies for managing herbicide-resistant weeds in corn and soybean systems. He shares insights on waterhemp, cover crop biomass, harvest weed seed control, electrocution technology, precision spraying, and why residual herbicides still matter. Listen now on all major platforms!"Herbicide resistance continues forcing major changes in weed management programs across corn and soybean systems, especially with waterhemp and Palmer amaranth spreading rapidly."Meet the guest: Dr. Kevin Bradley is a Professor and State Extension Weed Scientist in the Division of Plant Science and Technology at the University of Missouri. His extension and research work focuses on applied weed management in corn, soybean, and forage systems, with extensive work on herbicide-resistant waterhemp. He earned his PhD from Virginia Tech and has served at the University of Missouri since 2003. Listen to The Crop Science Podcast Show with Dr. Kevin Bradley on all major platforms.Liked this one? Don't stop now — Here's what we think you'll love!What you will learn:(00:00) Highlight(00:59) Introduction(05:00) Herbicide resistance trends(06:02) Cover crops(07:37) Harvest seed control(15:33) Weed electrocution(21:30) Precision spraying(25:25) Final questionsThe Crop Science Podcast Show is trusted and supported by innovative companies like:- Loam Bio

Let's take a breath and examine the exquisite contradictions of the modern Left. These are the people warning that your carbon footprint will murder the planet in a slow apocalyptic bake. The same ones who unleashed a virus, weaponized the panic, and turned it into the perfect mechanism for election interference and pharmaceutical windfalls. Precision timing, wasn't it? ICE just pulled 700,000 violent criminals off American streets. Actual predators with rap sheets longer than most congressional careers. Democrats' response? Defund the agency immediately. Because apparently the real public safety threat is the people removing the threats. They came within striking distance of nominating an actual Nazi for Senate in Maine. Not hyperbole, not online slang — the real article. Yet we're still lectured daily about which side endangers democracy. In Los Angeles, the mayor's race looks like it was decided with the same creative bookkeeping that defines their national playbook. The frontrunner presided over burning streets and an exploding homelessness crisis she swore she would fix. Now Spencer Pratt claims he's holding audio receipts that could expose the entire operation. Democrats treat clean elections the way vampires treat sunlight — they'll do anything to keep it away. Cheating isn't a tactic for them. It's the default setting. And the Trump contortions remain comedy gold. The man who struck Iran's nuclear ambitions, collapsed their economy, and left them economically gasping is now portrayed as some kind of reckless warmonger desperate to “pay them off” to end a conflict that isn't even officially a war. The mental yoga required to sell that story should qualify for the Olympics. They shrug at systemic welfare fraud that drains billions, but the sight of a self-made trillionaire sends them into convulsions. A man who generated that wealth by building products people voluntarily buy — no coercion, no subsidies, no mandates. That offends their sensibilities more than endless dependency schemes. So instead of acknowledging human achievement, they pivot straight to outrage theater. The world's first trillionaire deserves fireworks. They're delivering eulogies and pitchforks. This and plenty more on today's show. So here are the questions worth asking out loud: How does a political faction simultaneously fear productive billionaires and coddle career criminals? When did preventing fair elections become their most consistent skill set? And if innovation and voluntary exchange trigger them more than chaos and dependency, what exactly are they conserving — because it clearly isn't progress? Lines are open. Let's hear it.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the experience you think makes you an outsider in the design industry is actually your greatest advantage? In this episode of Designed for the Creative Mind, Michelle Lynne sits down with interior designer Katie Rainey to discuss her journey from Doctor of Physical Therapy to owner of a thriving interior design firm specializing in waterfront and lifestyle-driven homes. Katies design philosophy is that beauty and function are necessities, not luxuries.  With a Doctorate in Physical Therapy and a background in human movement, she crafts spaces that are both beautiful and intuitively designed for real life.  She partners with busy families and professionals seeking solace in nature - whether by the water in Annapolis or in the mountains of New Hampshire - guiding them through the intricacies of a renovation or a new build.  With deep construction knowledge, she collaborates closely with builders and architects to ensure seamless execution from concept to completion.  As part of a military family, Katie has lived across the U.S. and in Europe.  She draws inspiration for her designs from this global design perspective, having lived in diverse landscapes. Katie shares how she initially hid her medical background, believing it had little relevance to design, only to discover that her expertise in movement, ergonomics, and human behavior became one of her strongest differentiators. From designing custom solutions that improve clients' daily lives to building a business rooted in confidence, process, and professionalism, Katie offers valuable lessons for designers at every stage of business. The conversation also explores networking, pricing, client communication, boundaries, and the mindset shifts that helped Katie transition from treating design as a passion to running it as a profitable business. Whether you're transitioning from another career, struggling to communicate your value, or looking for encouragement to own your unique story, this episode is packed with practical wisdom and inspiration. In This Episode, We Discuss: Katie's transition from physical therapy to interior design Why your previous career can become your biggest business advantage Using ergonomics and human movement to create more functional homes How Katie found her unique positioning in the design industry The mindset shift from hobbyist to business owner Learning to separate emotion from sales conversations The "Pass the Salt" approach to discussing money with clients Why clear processes create better client experiences Educating clients through deliverables and expectations The importance of boundaries and scope management Networking strategies that helped Katie build a business in a brand-new market How confidence and consistency lead to stronger business growth Balancing motherhood, business ownership, and personal fulfillment Key Takeaways Your Past Experience Is Part of Your Expertise Katie spent years downplaying her background as a physical therapist before realizing it gave her a unique perspective that directly benefits her clients. The skills, knowledge, and experiences from previous careers often become the very thing that sets designers apart. Design Is More Than Making Things Beautiful A successful design must function for the people who live in it. Katie's understanding of ergonomics and movement helps her create spaces that support her clients' lifestyles while remaining beautiful. Confidence Comes from Process One of Katie's biggest business breakthroughs came from developing a clear process and communicating it effectively. When clients understand what to expect, they feel more confident moving forward. Networking Doesn't Have to Be Complicated From introducing herself to architects to striking up conversations at the gym and ice rink, Katie demonstrates that meaningful business relationships often start with a simple conversation. Business Growth Requires Personal Growth Success isn't just about improving your design skills. It's about developing confidence, setting boundaries, understanding your value, and learning how to lead clients through decisions. Memorable Quotes "Own your background. Whatever you did before design, there's something there that makes you a better designer." "If it looks beautiful but doesn't function for you, what's the point?" "You're not trying to convince clients to hire you. You're guiding them as the expert." "We are a for-profit company, not a non-profit." "We're most memorable in person, not behind our computer." "Whoever is going to hire me isn't going to hire you because I'm not you and you're not me." Connect with Katie Rainey Website: katieraineydesign.com Instagram: @katieraineydesign Facebook: Katie Rainey Design Connect with Michelle Lynne If you enjoyed this episode, be sure to subscribe, leave a review, and share it with a fellow interior designer who could benefit from today's conversation. For coaching, mentorship, and business resources for interior designers, visit our website at thedesignbakehouse.com.  Loved This Episode? Leave a review and share this episode with another designer who needs the reminder that their unique background isn't something to hide—it's something to build on.  

This week we talk about: Zoho Community Spaces: Building and Managing Online Communities Zoho CRM: Record Sharing for Activities Modules Zoho Forms: Spotlight Forms Our Code Share, Read, Tip and Question of the Week Read the show notes: https://zenatta.com/episode-410/    ⚖️ Avalara AvaTax for Zoho CRM ⚖️ Accurate Tax. Zero Guesswork.

After 5 long years of waiting Gustav Iden FINALLY joins us on The Triathlon Hour. This was a podcast we thought might never happen because Gustav almost never does these long format, sit down podcasts. Gustav is the 2022 Ironman Kona World Champion, 2019 & 2021 Ironman 70.3 World Champion, PTO Canadian Open champion and went on a 4 year undefeated streak from 2019-2022 in long course triathlon. We ask him all the training, racing & life questions we've been waiting to and that we know YOU want to hear. This podcast was worth the wait.  Try NOMIO for yourself. Discount code - TTH15 (for 15% off). In Europe - https://drinknomio.com In America - go to thefeed.com and search “Nomio” In Australia - go to aidstation.com.au and search “Nomio” Precision Fuel & Hydration: Use the code TTH15 to get 15% off your first order with Precision at their website. We would LOVE if you could tell Precision you heard about them from The Triathlon Hour in their "how did you hear about us?" question when purchasing - it helps support the podcast. Pillar Performance: Use the discount code TTH15 to get 15% off your first order with Pillar Performance at their website or if you're in North America use the TTH15 discount code at The Feed.  

In this episode, we take you inside the world of elite bike fitting with Ivan O'Gorman, a world-renowned fitter based in Niwot, Colorado who works with top professional triathletes and cyclists. We break down why a professional fit is one of the highest ROI investments you can make—impacting comfort, power, aerodynamics, and injury prevention. Ivan shares his approach to assessing athletes, the technology behind modern fitting, and real-world examples of how small positional changes drive big performance gains. Whether you're new to the sport or chasing your next PR, this episode will help you understand what it takes to ride like the pros.Vespa Power Endurance helps you tap into steady, clean energy—so you stay strong, focused, and in the zone longer. Vespa isn't fuel—it's a metabolic catalyst that helps your body use more fat and spare precious glycogen.Whether you're training for your next PR or racing long, Vespa helps you go the distance with sustained energy and faster recovery.Home of Vespa Power Products | Optimizing Your Fat MetabolismUse discount code 303endurance20Grit2Greatness Links & Calls to Action Website: Grit2Greatness Endurance Coaching Facebook: @grit2greatnessendurance Instagram: @grit2greatness_endurance Ambassador Application: https://forms.gle/mQjPbyzjAmmBhM6m9 Become a Team Member: Getting Started with Grit2Greatness - Google Forms Podcast Subscription: Grit2Greatness Endurance - Podcast - Apple Podcasts

Elliott Lorenz took an unusual path into consumer lending, moving from applied mathematics and high-frequency trading into the business of pricing credit risk. Today he is the CEO and co-founder of Edge Focus, a technology-enabled private credit firm that sits between consumer lending platforms and the institutional investors who want to deploy capital into the asset class. In this episode, Elliott explains how the firm's credit engine works, why speed is its biggest edge, and how he reads the recent wave of criticism aimed at private credit.What We CoveredFrom engineering and applied math to high-frequency tradingWhat Michael Lewis's Flash Boys got right and wrong about HFTSpotting an edge in LendingClub's public loan dataTurning a data-science hobby into Edge FocusThe Origin credit engine and how it makes decisionsExpanding a lender's credit box with an orthogonal view of creditModeling with a single month of payment historyUpdating a credit model within a dayThe Lens portfolio analytics toolWhere alpha comes from beyond the underwriting modelFraud and asset liability mismatch in private creditBuilding the EDGEX ABS shelf and partnering with FortressProving ML models are free from biasWhere consumer lending goes over the next few yearsKey TakeawaysEdge Focus competes less on having a single better model and more on combining technology, capital, and platform relationships in one package, which Elliott calls the firm's "big unlock."The firm can incorporate even a single month of payment history into its models and push an update within a day, letting it react to macro shifts faster than firms that wait 12 to 24 months for data.Most of the recent private credit criticism falls into two buckets, fraud and asset liability mismatch, and Elliott sees the fraud cases as largely idiosyncratic and the redemption problems as a function of investors misjudging illiquid assets.Because Edge Focus invests its own capital alongside partners rather than acting as a pure technology vendor, its incentives are tied directly to loan performance.About Elliott LorenzElliott Lorenz is the CEO and co-founder of Edge Focus, a technology-enabled private credit firm focused on consumer lending. He trained as an engineer and applied mathematician, earned a master's in finance from Princeton, and spent several years in high-frequency trading before bringing those modeling techniques into consumer credit in 2013.Connect with Fintech One-on-One:Tweet me @PeterRentonConnect with me on LinkedInFind previous Fintech One-on-One episodes

Why are more people becoming afraid of vaccines than the diseases vaccines were created to prevent? The answer is not simply a lack of information. In many ways, vaccines have become victims of their own success.For decades, widespread vaccination helped push diseases like measles, polio, pertussis, and smallpox out of everyday life. Many of us no longer live with the visible fear of these infections, their complications, or the way they can destabilize families, communities, and healthcare systems.But when the disease feels distant, the vaccine can start to feel like the bigger threat.That shift is now changing public health.Rather than assuming vaccine hesitancy is only about ignorance or defiance, we need to look more carefully at:• why people can become more suspicious of vaccines when they no longer see the diseases vaccines helped control• How misinformation, fear, personal experience, politics, history, and social media can shape health decisions• Why highly educated people can still be vulnerable to vaccine misinformation• how confusing a side effect, adverse event, or normal immune response with a true allergy can create long-term fear• Why egg allergy is no longer the vaccine barrier many people still believe it is• And how declining vaccination rates can allow diseases like measles and pertussis to reemergeVaccine education has to move beyond simply telling people what to do. We need clearer, more compassionate conversations that acknowledge fear while helping people separate facts from fiction.In this upcoming episode, I'm joined by Dr. Joyce Yu, associate professor of pediatrics and director of the Food Allergy Program at Columbia University Irving Medical Center.Together, we explore:What is driving the rise of vaccine hesitancyWhy vaccine-preventable diseases can return when communities let their guard downHow allergists help patients understand whether a vaccine reaction is truly an allergyAnd why rebuilding trust requires listening, clarity, and evidence-based conversationIf you or someone you love has ever felt uncertain, afraid, or confused about vaccines, allergic reactions, side effects, or conflicting health information, this conversation offers a grounded look at how fear spreads, how misinformation takes hold, and why protecting public health depends on rebuilding trust.Guest BioDr. Joyce Yu is an associate professor of pediatrics and director of the Food Allergy Program at Columbia University Irving Medical Center. She is an allergy and immunology specialist with clinical and scientific expertise in food allergy, immunology, vaccine-related concerns, and immune system function. Dr. Yu received her medical education at the Icahn School of Medicine at Mount Sinai, completed her residency at Northwestern/Lurie Children's Hospital, and completed her fellowship in Allergy and Immunology at Mount Sinai. Her postdoctoral work focused on toll-like receptor signaling and memory B cell development, mechanisms that are closely connected to how the immune system develops lasting protection. She is a fellow of both the American College of Allergy, Asthma & Immunology and the American Academy of Allergy, Asthma & Immunology. She is also a former president of the New York Allergy and Asthma Society and has held leadership roles within the Clinical Immunology Society. Connect with Dr. Yu on LinkedIn.About Your HostHosted by Dr. Deepa Grandon, MD, MBA, a triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidence-based lifestyle medicine.Disclaimer ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced.Work With Me Learn More About My Soon-to-Launch Telemedicine PlatformExciting news. My virtual medical platform is launching soon! If you're looking for personalized, evidence-based care in allergy, immunology, and lifestyle medicine, stay tuned.Visit drdeepa-tlc.org and click on “Learn More” to join the waitlist and be the first to receive updates about services, membership options, and launch details.Precision care. Personalized guidance. Wherever you are.DevotionalsWant to receive a devotional every week from Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit drdeepa-tlc.org to subscribe for free.Trauma CoursesReady to deepen your understanding of trauma and kick-start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents, and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.

Please visit answersincme.com/CNW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephen V. Liu, MD and Amber Fake. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the evolving patient-centered management of HER2-mutant NSCLC, focusing on the use of HER2-targeted TKIs. Upon completion of this activity, participants should be better able to: Describe how HER2-targeted TKIs may address the clinical needs for diverse patient populations with HER2-mutant NSCLC; Implement evidence-based molecular profiling to identify HER2 alterations in NSCLC; Evaluate the clinical evidence of current and emerging HER2-targeted treatments; and Integrate shared decision-making strategies to align preferences for patients with HER2-mutant NSCLC.

Please visit answersincme.com/CNW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephen V. Liu, MD and Amber Fake. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the evolving patient-centered management of HER2-mutant NSCLC, focusing on the use of HER2-targeted TKIs. Upon completion of this activity, participants should be better able to: Describe how HER2-targeted TKIs may address the clinical needs for diverse patient populations with HER2-mutant NSCLC; Implement evidence-based molecular profiling to identify HER2 alterations in NSCLC; Evaluate the clinical evidence of current and emerging HER2-targeted treatments; and Integrate shared decision-making strategies to align preferences for patients with HER2-mutant NSCLC.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries is one of constant evolution, characterized by scientific advancements, strategic mergers, and regulatory maneuvers that shape the future of healthcare. In a significant scientific breakthrough, Merck & Co. and Gilead Sciences have made strides in HIV treatment with the development of a weekly pill. This innovative regimen combines Merck's islatravir with Gilead's lenacapavir, showing promise in two phase 3 trials. If approved, this long-acting oral therapy could revolutionize HIV care by offering a more convenient dosing schedule, potentially improving patient adherence and outcomes substantially. This novel regimen signifies progress towards simplifying HIV treatments with once-weekly dosing. Meanwhile, in the oncology sector, Gilead's Trodelvy faced challenges when combined with Merck's Keytruda as a first-line treatment for PD-L1-high non-small cell lung cancer. The phase 3 EVOKE-03 trial was terminated, shifting attention to competitors like AstraZeneca and Daiichi Sankyo, who continue to advance their own therapies in this area. In a strategic move to bolster its position in lung cancer treatment, GlaxoSmithKline (GSK) is acquiring Nuvalent for $10.6 billion, aiming to secure near-approval cancer therapies capable of challenging market leaders like Roche and Pfizer. This acquisition underscores the focus on targeted cancer therapies that increase treatment efficacy by honing in on specific genetic markers. Nuvalent's innovative pipeline of small molecule inhibitors targets drug resistance and mutations in cancer treatment—a strategic addition to GSK's portfolio aimed at enhancing its position amidst rapid advancements and intense competition in oncology. In diabetes and obesity management, Eli Lilly is advancing with its new oral GLP-1 receptor agonist, Foundayo (orforglipron), which has shown competitive efficacy over oral semaglutide. Analysts see Lilly's progress as strengthening its leadership in the growing obesity drug market. Similarly, AstraZeneca is making progress with its own GLP-1 candidate, elecoglipron, as phase 2 data sets the stage for pivotal studies. Promising clinical trial data from Eli Lilly's retatrutide for obesity-related conditions and AstraZeneca's elecoglipron suggest a strengthening pipeline for GLP-1 receptor agonists known for their dual effects on weight management and glycemic control. On the diagnostics front, Roche reaffirms its €600 million investment in Germany amid industry retrenchments by companies like Eli Lilly and Boehringer Ingelheim. However, Roche remains cautious about future risks due to shifting economic conditions. The financial dynamics within biotech are also noteworthy. Parabilis Medicines is planning a potentially record-setting IPO following Kailera Therapeutics' successful public offering earlier this year. These trends indicate strong investor confidence and an influx of funding towards innovative cancer therapies. Meanwhile, CeQur's $100 million Series E funding round aims at accelerating insulin patch delivery systems' commercial growth—highlighting ongoing innovation in diabetes management solutions. Regulatory updates reveal AstraZeneca facing reprimands from the UK marketing watchdog due to repeated breaches related to LinkedIn activities—an ongoing challenge in pharmaceutical marketing compliance. The integration of digital health solutions continues apace as ixlayer partners with Vertex Pharmaceuticals to launch a digital acute pain management platform. This initiative aims at improving patient care by reducing reliance on opioid-based treatments. These developments paint a picture of an industry where scientific innovations, regulatory hurdles, and technological advancements intersect to shape future therapeutic landscapes. Precision oncology is another area witnessing substantial growth. The landscape also sees notable activity in rare disease therapeutics. Johnson & Johnson's Talvey has gained acceptance in Scotland for treating relapsed multiple myeloma using bispecific antibody technology—a trend toward leveraging immune system targeting technologies to enhance cancer treatment efficacy. Moreover, Zai Lab's Tivdak received approval from China's NMPA for cervical cancer treatment based on Phase 3 data, highlighting the rise of antibody-drug conjugates (ADCs) as potent oncology therapies due to their targeted delivery mechanisms. On the research collaboration front, AlzeCure Pharma's partnership with Eli Lilly focuses on Alzheimer's disease research through Alzstatin ACD680—a small molecule targeting neurodegenerative pathways—a testament to the collaborative efforts needed to tackle complex diseases like Alzheimer's. However, challenges persist as Bial discontinued its GCase activator program after failing Phase 2b trials for Parkinson's patients with GBA1 variants—a stark reminder of the high-risk nature inherent in drug development despite initial promise. These myriad developments underscore a vibrant period within pharmaceutical and biotech sectors where scientific advancements rapidly translate into actionable therapies promising substantial improvements in patient care by addressing unmet medical needs globally.Support the show

Hosted by MJGibson live at MJBizCon 2025, this episode—sponsored by SHOPLINE in association with ICBC—features Grant Schuster and Jim Pivaldi of AccelerantManufacturing on how Swiss-engineered automation is reshaping cannabis cone production. From laser-engraved customization and 200M+ monthly output to a production-as-a-service model that redefines scalability, the conversation cuts straight to what's changing in cannabis manufacturing and why it matters.WEBSITE: https://cannatechtoday.com/Make sure to follow our other social media platforms to stay up-to-date on all things Cannabis & Tech Today.https://twitter.com/cannatechtodayhttps://www.facebook.com/CannaTechTodayhttps://www.instagram.com/cannatechtoday

"You never get a second shot at quality—do it right the first time." Episode Summary In this episode, we sit down with Gage Moulding, the Vice President of HSM Ammunition, to talk about all things ammo. We dig deep into the science and consistency required to build truly reliable ammunition, the importance of family culture in a manufacturing business, and how real-world feedback from shooters shapes the products HSM produces. We also explore how the industry reacts to supply chain challenges, changing regulations, and technological advances. Whether you're a competitive shooter, a hunter, or a casual range enthusiast, this episode delivers the kind of insider perspective you've always wanted on what it takes to put the highest quality rounds in your magazine. Call to Action  1. Subscribe and leave us a comment on Apple or Spotify 2. Follow us on all of our social media: Instagram Youtube 3. Grab some cool TGE merch 4. Ask us anything at AskMikeandKeith@gmail.com 5. Be sure to support the sponsors of the show. They're a big part of making the show possible. Show Sponsors HSM Ammunition: Proudly made in the USA with tight quality control. Check them out at hsmammunition.com or your local sporting goods store. OnSight Firearms Training (OFT): Real-world defensive shooting instruction by pros who walk the walk. Find a course that meets your needs at OFTLLC.us Key Takeaways Modern factory ammo can rival handloads in consistency and performance due to advanced quality control systems. HSM's company culture is built around family values and customer service, ensuring your concerns are addressed by real experts. Longevity among employees (loaders with 17+ years at HSM) brings unmatched institutional knowledge and consistent manufacturing processes. Supply chain disruptions (especially for powder and primers) remain the industry's biggest challenge. Preparedness (safety stock) is essential. Real-world feedback from hunters, competitors, and law enforcement directly influences new product development at HSM. Ammunition price increases reflect rising costs across the board, not higher profits for manufacturers. Not all calibers are created equal—find out why .44 Magnum is underrated and the myth behind "just fill it to the top" when reloading. Guest Information Name: Gage Moulding Position: Vice President, HSM Ammunition Background: Former Army Officer, extensive experience in manufacturing and distribution, passionate about hunting, fishing, and shooting sports. Keywords ammunition manufacturing, HSM Ammunition, ammo quality control, factory ammo vs handloads, competitive shooting, hunting ammo, family business, American-made ammo, ammo supply chain, powder shortage, shooting sports, reloading myths, gun industry trends, best rifle ammo, premium projectiles, .44 Magnum, subsonic ammunition

Send us Fan MailIn this episode of Small-Cap Spotlight, Ning Ding, Chairman and CEO of ZJK Industrial, joins WTR's Tim Gerdeman, Co-Founder and Chief Marketing Officer and equity analyst Eric Goldstein to unpack the company's record 2025 results, its expanding role in the AI infrastructure supply chain, and a multi-year plan to scale production globally — including a new Vietnam facility and a planned U.S. R&D and testing center.ZJK Industrial (NASDAQ: ZJK) is a Shenzhen-based precision metal parts manufacturer with one of the most technically demanding portfolios in global manufacturing — supplying AI infrastructure, liquid cooling for high-performance computing, electric vehicles, aerospace, medical devices, and advanced electronics.

Architect and engineer Noémie Aureau founded Atelier No'Au after nearly eight years at Renzo Piano Building Workshop in Paris. Her work brings together technical precision, environmental awareness and a sensitive reading of place.In this short episode of Com d'Archi, she reflects on the origins of her practice and explains how engineering and architecture can work together to shape meaningful projects. For her, constraints are not obstacles but opportunities to create elegant, resilient and lasting architecture. The conversation also focuses on one of Atelier No'Au's first major projects: the extension of a holiday resort on the Brittany coast. Designed through an off-site construction approach, the project combines timber structures, prefabricated components and careful integration within an exceptional natural landscape. Through this example, Noémie Aureau discusses design for assembly, low-carbon construction and the possibilities offered by industrialised timber building systems developed with SYbois, a key partner in both the project and this podcast.A concise and inspiring episode about architecture, innovation and the search for balance between technology, nature and human experience.Audio consulting: NyreTeaser image © Com d'Archi PodcastSYbois, the low-carbon timber-frame wall and façade construction solution. The SYbois concept is the art of designing a wall around its opening: the window system it integrates.___If you like the podcast do not hesitate:. to subscribe so you don't miss the next episodes,. to leave us stars and a comment :-),. to follow us on Instagram @comdarchipodcast to find beautiful images, always chosen with care, so as to enrich your view on the subject.Have a wonderful week! Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Talia Cohen Solal, CEO and Co-Founder of NeuroKaire, is focused on improving patient outcomes of those with depression by predicting the most effective antidepressant for each individual. The NeuroKaire platform personalizes psychiatric treatment by creating neurons from a patient's blood sample to model their brain and test drug responses, pointing the way to an effective treatment, avoiding prolonged trial-and-error. This is a significant advancement over existing pharmacogenomic tests, which primarily provide information on drug metabolism rather than drug efficacy. This technology is also being applied to other conditions like ADHD, schizophrenia, bipolar disorder, and epilepsy.   Talia explains, "At NeuroKaire, we are dedicated to improving patient outcomes in psychiatry and neurology. To do that, we've developed a platform to predict which antidepressant is best for each patient and are expanding out to other disease indications to achieve that mission."   "Basically, around 2006, Yamanaka and his colleagues discovered that you could take any cell in the body and turn it back into a stem cell. And that changed everything for the field. So what we can do now is we can take a blood sample, turn it back into a stem cell, and then turn it into whatever cell type we'd like. And our mission is to help people with brain disorders and psychiatric disorders. And so we turn those stem cells into neurons. And now we have a model of the patient's brain. Now we have neurons from the patient's brain and a little ecosystem mimicking a patient's brain. And there we can actually see what's going wrong in the connectivity, what's changed in those patients, and what drugs are going to have the best outcome to reverse those changes." #NeuroKaire #PrecisionPsychiatry #MentalHealth #Antidepressants #BrightKaire #PersonalizedMedicine #PGx #Neuroscience #HealthcareInnovation neurokaire.com Download the transcript here

Talia Cohen Solal, CEO and Co-Founder of NeuroKaire, is focused on improving patient outcomes of those with depression by predicting the most effective antidepressant for each individual. The NeuroKaire platform personalizes psychiatric treatment by creating neurons from a patient's blood sample to model their brain and test drug responses, pointing the way to an effective treatment, avoiding prolonged trial-and-error. This is a significant advancement over existing pharmacogenomic tests, which primarily provide information on drug metabolism rather than drug efficacy. This technology is also being applied to other conditions like ADHD, schizophrenia, bipolar disorder, and epilepsy.   Talia explains, "At NeuroKaire, we are dedicated to improving patient outcomes in psychiatry and neurology. To do that, we've developed a platform to predict which antidepressant is best for each patient and are expanding out to other disease indications to achieve that mission."   "Basically, around 2006, Yamanaka and his colleagues discovered that you could take any cell in the body and turn it back into a stem cell. And that changed everything for the field. So what we can do now is we can take a blood sample, turn it back into a stem cell, and then turn it into whatever cell type we'd like. And our mission is to help people with brain disorders and psychiatric disorders. And so we turn those stem cells into neurons. And now we have a model of the patient's brain. Now we have neurons from the patient's brain and a little ecosystem mimicking a patient's brain. And there we can actually see what's going wrong in the connectivity, what's changed in those patients, and what drugs are going to have the best outcome to reverse those changes." #NeuroKaire #PrecisionPsychiatry #MentalHealth #Antidepressants #BrightKaire #PersonalizedMedicine #PGx #Neuroscience #HealthcareInnovation neurokaire.com Listen to the podcast here

What if the invisible signals surrounding us every day were quietly affecting our health, our food, our livestock, and even future generations?In this eye-opening episode, David DeHaas sits down with Daniel Stachowski of Essential Energy to explore the growing impact of electromagnetic fields (EMFs), cell towers, wireless technology, precision agriculture, and data-driven farming practices.From brain fog and fertility concerns to declining food quality, livestock health issues, and the rise of smart farming technologies, this conversation uncovers how modern electromagnetic pollution may be influencing every aspect of life—from human biology to agriculture.If you're concerned about your family's health, food quality, farming practices, environmental sustainability, or the future of agriculture, this is an episode you won't want to miss.Are EMFs silently impacting your health, fertility, food supply, and livestock production?In this fascinating discussion, David DeHaas welcomes Daniel Stachowski, founder of Essential Energy, to examine the growing concerns surrounding electromagnetic field (EMF) exposure and its potential effects on people, animals, crops, and the environment.Daniel shares his personal journey from working with major technology companies like Microsoft and Amazon to researching the biological effects of electromagnetic radiation after health challenges within his own family led him to investigate root causes of illness.Together they discuss:• EMFs and brain fog• Cell towers and wireless radiation• Fertility concerns and reproductive health• Livestock productivity and animal wellness• Precision agriculture and smart farming• Food nutrient density and quality• Data centers and electromagnetic pollution• Regenerative agriculture• Farm privacy concerns• The future of food production• Environmental health and sustainability• How EMFs may affect plants, pollinators, and ecosystemsThe conversation also explores emerging research on nutrient density in food produced on EMF-safe farms, potential impacts on dairy production and livestock fertility, and what farmers and consumers can do to create healthier environments.Whether you're a farmer, rancher, health-conscious consumer, parent, or simply curious about the relationship between technology and biology, this episode provides a thought-provoking perspective on one of the most overlooked topics in modern health and agriculture.ABOUT THE GUEST:Daniel StachowskiFounder, Essential EnergyWebsite:www.EssentialEnergy.usABOUT THE HOST:Living Waters Wellness CenterDavid DeHaas855 S Curtis RdBoise, ID 83705Office: (208) 378-9911Connect with Living Waters Wellness Center to learn more about holistic health, detoxification, regenerative wellness, nutrition, and natural healing strategies.Thank you for listening to the Whole Body Detox Show with David DeHaas.If you found value in this episode, please like, subscribe, and share it with friends, family members, farmers, ranchers, and anyone interested in improving their health and understanding the impact of modern technology on our environment and food supply.For more expert interviews and natural health solutions, visit:www.livingwaterscleanse.comUntil next time, remember: your health is your greatest asset, and understanding the environment around you is a powerful step toward protecting it.Support the showReady for your healing journey?Visit our website: www.LivingWatersCleanse.com Or give us a call at: (208) 378-9911Stem Cell Activation Patches:www.StemCellPatch.netGet your Supplements and Natural Body Products Here:www.livingwaterscleanse.com/supplementsQI-Shield EMF Devices:Protect your whole home or office with a touric shield from EMF's. 1. QI Shield Covers 16'x16'2. QI Home Covers 50' x 50'3. QI Max Covers 250'x250'Click on link and enter Livingwaters in discount code section during checkoutMagnesium Soaks:Follow us on our socials: Living Waters Wellness CenterBitChute: www.bitchute.com/livingwaterswellnessRumble: www.rumble.com/living...

As privacy regulations tighten across the healthcare sector, traditional touch-based tracking models are distorting the true impact of cross-channel marketing campaigns. In this episode, we explore how advanced Marketing Mix Modeling (MMM) and privacy-first identity tracking can reveal your actual marketing channel performance without sacrificing compliance. Learn how to transition from platform vanity metrics to mathematically verified, incremental business growth. Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

********** This week we talk about: Zoho: Announcements Hub Zoho Analytics: May 2026 Feature Updates Zoho Inventory: April & May 2026 Updates Our Code Share, Read, Tip and Question of the Week Read the show notes: https://zenatta.com/episode-409/    ⚖️ Avalara AvaTax for Zoho CRM ⚖️ Accurate Tax. Zero Guesswork.

Dr. Pedro Barata and Dr. Bridget Keenan discuss the innovative bioengineering allowing clinicians to target historically "immune-cold" tumors, the logistical evolution of bringing bispecific therapies safely into outpatient community clinics, and the complex future of predictive biomarkers and resistance mechanisms. LINK TO FULL TRANSCRIPT

He was the man who turned sparse, muscular prose into a blueprint for the 20th century. But before the Nobel Prize, the big-game hunting, and the larger-than-life legend, there was just a young man writing in the cafés of Paris.In this episode of History Ignited, we strip away the myth to find the man behind the typewriter. We explore how Ernest Hemingway's experiences in the Great War and the Lost Generation shaped his relentless pursuit of "the true sentence." From the sun-drenched rings of Spanish bullfights to the quiet complexities of his most iconic short stories, we trace the literary evolution of one of America's most polarizing figures. Tune in as we examine the man who didn't just write about life—he lived it to its breaking point.Send us Fan MailAbout History Ignited: History Ignited is the award-winning kids and family history podcast inspired by Billy Joel's We Didn't Start the Fire. Each short episode explores the real stories behind the people, events, inventions, and cultural moments that shaped the world from the 1950s through the 1980s. Winner of the 2025 Webby People's Voice Award for Best Kids & Family Podcast.

Lucy Charles-Barclay, the Ironman World Champion, multiple Ironman 70.3 World Champion and all-round superstar joins us to give you as many of her training secrets as you've ever heard before. Lucy said before the podcast that whatever I asked, she would give us all the details about - so we took advantage of that! Lucy also gives us some great behind the scenes insight that she'd never talked about before with her racing & life. This was an in-depth chat with the triathlete everyone loves.  Try NOMIO for yourself. Discount code - TTH15 (for 15% off). In Europe - https://drinknomio.com In America - go to thefeed.com and search “Nomio” In Australia - go to aidstation.com.au and search “Nomio” Precision Fuel & Hydration: Use the code TTH26 to get 15% off your first order with Precision at Precision Fuel & Hydration Pillar Performance: Use the discount code TTH15 to get 15% off your first order with Pillar Performance at their website or if you're in North America use the TTH15 discount code at The Feed. Nerd Belts Discount code - TTH26 (for 15% off) Click here to buy yourself a Nerd Belt

What if trauma is more than a psychological experience? In this episode, I sit down with Dr. Aimie Apigian, a Preventive and Addiction Medicine Physician and founder of Trauma Healing Accelerated™, to explore how trauma becomes stored in the body and influences the nervous system, metabolism, immune function, and overall health. Together, we challenge the conventional view of trauma and examine why unresolved survival responses can contribute to chronic symptoms, fatigue, dysregulation, and disease. We discuss the differences between stress and trauma, the body's survival adaptations, the five patterns of stored trauma, and the critical role of the autonomic nervous system in recovery. Dr. Aimie shares her Biology of Trauma® framework, explaining how healing goes beyond mindset and requires creating safety within the body to restore resilience, regulation, and lasting health. If you've ever wondered why some patterns seem impossible to change, why chronic symptoms persist despite doing everything "right," or why healing often feels incomplete, this conversation may completely transform the way you think about trauma, health, and recovery.   Key takeaways: Trauma is not limited to psychological impacts but involves complex biological adaptations that affect the entire body system. Stress and trauma are distinct, with trauma representing an overwhelming threat that triggers a different survival response. Unresolved trauma can lead to chronic health conditions, including autoimmunity and fatigue, highlighting the need for integrative healing methods. Healing from trauma requires creating an environment of safety before addressing deeper emotional and physiological issues. Effective trauma therapy should incorporate mind work, body somatic work, and biology for comprehensive healing.   More About Dr. Aimee Apigian: Dr. Aimie Apigian is a double board-certified physician in Preventive and Addiction Medicine, with advanced training in biochemistry, public health, and functional medicine. She is the national bestselling author of The Biology of Trauma (foreword by Gabor Maté), featured on the USA TODAY Best-Selling Booklist and recipient of multiple book awards. She is known for making trauma healing both precise and deeply human, bridging functional medicine, attachment science, and trauma therapy to show how the body stores survival patterns and what it specifically needs to heal. Through her Biology of Trauma® framework, she integrates somatic work, parts work, and targeted biology to identify where the system is blocked and restore its capacity for healing through a structured, measurable sequence. Dr. Aimie is the founder of Trauma Healing Accelerated™ and host of the Biology of Trauma® Podcast, where she trains individuals and practitioners worldwide to move beyond insight into real, lasting change. Website Instagram Connect with me! Website Instagram Facebook YouTube

Host Seth Swerczek and Preston Lentfer continue the budget precision rifle project by breaking down the upgrades made to the Glenfield Model A in 6.5 Creedmoor. From aftermarket parts to setup changes, the duo compares the new dispersion results using the same Hornady ammunition from Part 1 to see whether the upgrades improved performance—or made things worse.

Right now, as you're reading this sentence, something remarkable is happening in your brain. Light waves from your screen hit your eyes, transform into electrical signals, and take on meaning. You understand what you're reading. This is language — our human superpower.But despite 150 years of intensive research, we still do not have a complete picture of how the brain actually accomplishes all of this. We don't even have a good answer to a seemingly simple question: Where in the brain does language happen? It turns out, the answer may be different in different people.Today we'll hear from neuro-linguist Cory Shain, one of the leaders of a new Big Ideas in Neuroscience project here at Wu Tsai Neuro that is combining multiple brain recording techniques to build individualized maps of the language network—and use these insights to improve brain implants for people who've lost the ability to speak or write due to brain injury or illness.Learn moreLaboratory for Computation & Language in Minds & BrainsLaboratory of Speech NeuroscienceNeural Prosthetics Translational LabBrainGateHow the Brain Processes Different Components of Language (Psychology Today, 2024)Big Ideas in Neuroscience tackle brain science of everyday life and more (Wu Tsai Neurosciences Institute, 2026)Study of promising speech-enabling interface offers hope for restoring communication (Stanford Medicine, 2025)The neuroscience of understanding (Stanford Momentum, 2025)Distributed Sensitivity to Syntax and Semantics throughout the Language Network(Journal of Cognitive Neuroscience, 2025)Hierarchical dynamic coding coordinates speech comprehension in the brain(Proceedings of the National Academy of Sciences, 2025)Send us a text!Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.We want to hear from your neurons! Email us at at neuronspodcast@stanford.eduLearn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn. 

On this episode of The Bandwich Tapes, I sit down with conductor, composer, and longtime contemporary music advocate Brad Lubman for a wide-ranging conversation about interpretation, rehearsal, composition, and the deeper responsibilities of making music with other people.Brad first came onto my radar through his work conducting Steve Reich's music, but this conversation quickly opened into something much larger. He talks about the way audiences often associate him with Reich's music, while reminding us that he had already built a substantial life in new music long before that connection began. From there, we get into a fascinating discussion about what conductors actually do, and why he resists the idea that great conducting is about imposing personality on a score. For Brad, the work begins with the composer's intentions and the discipline of bringing those intentions to life as clearly and honestly as possible.We also spend time on Brad's path as both a percussionist and a conductor, including how his early love of drums and rock music, and later of orchestral music, shaped the musician he became. He reflects on what percussion taught him about immediacy, time, and gesture, and how those lessons still inform the way he teaches conductors today. His thoughts on rehearsal are especially compelling: the idea that a conductor's role is not to dominate but to create conditions in which musicians can play with confidence, clarity, and artistry.A particularly rewarding part of this conversation centers on Brad's own music, especially his powerful piece Tangents for two pianos and two percussionists. He shares the origin of that work, how it emerged during a moment when he was considering stepping away from composition, and why it marked the beginning of a new phase in his musical language. We also talk about his long association with Steve Reich, Ensemble Signal, and the kinds of life-changing moments that can come from simply doing your work well and being ready when the right people are listening.By the end of the conversation, what comes through most clearly is Brad's seriousness of purpose and his belief in music as a communal act. Whether he is conducting, composing, teaching at the Eastman School of Music, or building programs with Ensemble Signal and major orchestras around the world, he approaches music with precision, humility, and an unwavering sense of service to the score and the people making it.Key TakeawaysBrad Lubman offers a thoughtful distinction between “interpretation” and serving the composer's intentions, arguing that great conducting begins with fidelity to the score rather than ego.He explains why so much of what audiences hear as a conductor's influence is actually shaped in rehearsal, not just in performance.Brad reflects on how his background as a drummer and percussionist sharpened his sense of time, touch, and physical gesture.We talk in depth about his piece Tangents and why that work marked a turning point in his life as a composer.Brad shares how key moments in his career — including his connection to Steve Reich and the New York premiere of City Life — came through preparation, reputation, and musical trust.He discusses the communal nature of orchestral music-making and his belief that an ensemble can model cooperation at the highest level.The conversation concludes with a look at his current work as a teacher, conductor, composer, and advocate for contemporary music worldwide.Music from the EpisodeMusic for 18 Musicians (Pulse) - Steve Reich (Ensemble Signal - Brad Lubman, Conductor)Radio Rewrite (I. Fast) - Steve Reich (Ensemble Signal - Brad Lubman, Conductor)Double Sextet (I. Fast) - Steve Reich (Ensemble Signal - Brad Lubman, Conductor)Tangents - Brad Lubman (Icaras Quartet)About the PodcastThe Bandwich Tapes is my chance to sit down with musicians, composers, songwriters, conductors, and creative artists I admire for honest conversations about craft, collaboration, career, and the deeper ideas that shape their work. It's a show about process, perspective, and the stories behind a life in music.Connect with the ShowEmail: contact@thebandwichtapes.com

Join the waitlist for One of One here!

Unlock precision shooting secrets to elevate your hunting and competitive game without breaking the bank. Whether you're experienced or new, this episode shows how competitive shooting enhances skills and decision-making. Dan Bertocchini and Justin Crossley explore how match scenarios mimic real hunting challenges, teaching ethical shot placement and gear refinement. Discover how competition boosts confidence and connects you with a passionate community. Tune in to transform your skills and redefine what's possible in the field. Afterwards discover how Kings Camo is revolutionizing hunting gear with modular systems that fit every hunt. Learn about their innovative XKG layering, lightweight packs, and stealth-enhancing technology. Elevate your hunting experience with insights from Andrew Pooch, head of product at Kings Camo. Talk then shifts towards the other Rokslide.com gear reviews and a recap of the latest Western news. PRSuit Series Kings Camo XKG series Cold Bow Challenge 2026 Howl for Wildlife- Take Action   Check out Rokslide's 2025 Best Gear- https://www.rokslide.com/best-gear-of-2025/   Visit Rokslide's Rokcast Forum to submit questions, request a topic or give feedback. To be a guest on Tipsy Tuesday please send an email to Sam@Rokslide.com   [ Rokcast is powered by onX Hunt. For 20% off, use Promo Code “Rokcast” at onX Hunt here https://www.onxmaps.com/hunt/app]

Join hosts Rick Hogg (founder of War HOGG Tactical and 29-year U.S. Army Special Operations combat veteran) and Mark Kelley (founder of Kelley Defense and U.S. Army combat veteran / law enforcement veteran) on the On The Range Podcast for an in-depth conversation with special guest Buck Holly, CEO and Founder of C&H Precision (CHPWS).   In this episode, Buck Holly shares his journey building C&H Precision from custom precision rifles to becoming a leader in rugged, direct-mount red dot optics, modular adapter plates, slide milling services, and innovative pistol upgrades trusted by competitive shooters, law enforcement, military professionals, and responsible armed citizens. Discover expert insights on choosing the right pistol optics, reliable mounting solutions, real-world durability testing, and the future of tactical gear designed for performance under pressure.   Whether you're looking to upgrade your Glock, Sig, Walther, CZ, or other carry pistol with the best red dot sights and adapter plates on the market, or simply want battle-tested advice from industry leaders, this episode delivers actionable takeaways to help you stay 1% better every day.   Listen/Watch Now and level up your firearms training and gear knowledge!

Editor's note: Download and listen to the audio version below and click here to subscribe to the Today in Manufacturing podcast.The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN).This week's episode is brought to you by Scientific Cutting Tools (SCT).Working with customers that include NASA, Caterpillar and Johns Hopkins demands a combination of proven and new-age strategies and processes. SCT recently offered a look behind the curtain in detailing how listening to their customers and paying attention to key industry trends has established a legacy of innovative problem-solving and an undeniable focus on cutting edge production and product technologies.These same principles have kept the company competitive for more than 60 years in an increasingly crowded marketplace, and led to internal practices focused on attracting new talent while simultaneously retaining vital experience.To learn more about their secrets to long-term success, download this behind-the-scenes report, "Built on Precision, Grounded in Integrity," right now.Every week, we cover the three biggest stories in manufacturing, and the implications they have on the industry moving forward. This week:- Missing Sticker Triggers Recall for Thousands of Teslas- North Carolina Sues Vietnamese EV Maker After Ongoing Delays- SendCutSend Raises $110 Million to Build 'Anything Factories'In Case You Missed It- Robot With 20 Legs and Eyes Built to Move, See in Any Direction Instantly- Blue Origin's $600 Million Expansion Project to Boost Upper-Stage Production in Florida- Slate Auto Nabs Michigan Grant to Expand EV HQPlease make sure to like, subscribe and share the podcast. And to email the podcast, you can reach any of us at Jeff, Anna or David@ien.com, with “Email the Podcast” in the subject line. Subscribe to our daily and weekly newsletters.

Hell yeah! Nothing says it's summertime like an atmospheric firehose! Hope you had a grand Memorial Weekend and that you let Bret Michaels honor the fallen in peace. Now let's party! NYC hosts half of the top 50 pizza spots in America and holds court in the top 5 spots in the entire world. Now in Charlotte, Keith skips Cook Out to try out America's 41st best: Pizza Baby. Keith also reviews entertainment juggernauts Star Wars: The Mandalorian & Yoda and The Boys series finale. He also dives into AI, featuring: ChatGPT making an animation based on Keith's new book, revisiting Keith trying to get Grok to speak to him as an apologetic ex, and Taxi Driver screenwriter Paul Schrader telling us that his AI girlfriend broke up with him. AD: This episode is brought to you by the new Shit Number smart toilet. “Precision analytics for your daily business.”

Host Seth Swerczek and Preston Lentfer put a bone-stock Glenfield Model A in 6.5 Creedmoor to the test to see just how much precision you can get on a budget. From the scope, rings, and bipod setup to testing three varieties of Hornady ammunition, the duo establishes a baseline for the rifle's dispersion capability before diving into upgrades. Stay tuned for Part 2, where aftermarket modifications are added to see if the improvements make a difference.

In this episode, Justine Reichman interviews Stacey Berger, a seasoned product developer and founder of Sum Of All, about her journey into creating precision skincare tailored for women in midlife. They explore the science behind hormonal skin changes, sustainable beauty practices, and the importance of intentional product formulation. Keywords skincare, menopause, sustainability, women in midlife, product development, hormonal skin, clean beauty, innovation, self-care, empowerment Key  topics Hormonal impact on skin during menopause The importance of science-backed ingredients Sustainable and clean beauty practices Building a brand with purpose and intention The role of collaboration with medical experts Chapters 00:00 Introduction to Essential Ingredients and Guest Introduction 01:42 Stacey's Journey in Product Development 03:47 The Transition to Entrepreneurship 06:29 Overcoming Challenges as an Entrepreneur 09:00 The Importance of Community and Support 13:31 Personal Experience with Perimenopause 16:40 Identifying the Market Gap 22:10 Precision Skincare Explained 29:28 The Intent Behind Clean Beauty 32:35 Navigating Clean and Sustainable Choices 34:53 Empowering Women Through Beauty 39:24 Sustainability Challenges in Product Development 40:44 Holistic Approach to Beauty and Wellness 42:28 The Role of Indie Brands in Beauty Innovation 44:24 Customer Impact Stories 49:16 Reassurance for Women in Midlife 51:04 Rapid Fire Insights on Beauty Guest links Instagram - https://www.instagram.com/some_of_all_beauty

Join us in this episode as Dr. Adrijana Kekic, Founder and CEO of Futurome, discusses her approach to helping leaders, executives, and high performers extend both lifespan and healthspan using science-backed precision tools.  Futurome is a concierge longevity company specializing in precision medicine for high performers. As a longevity pharmacist and expert in systems biology, Dr. Kekic uses multiomics, digital biomarkers, and AI-driven tools to create personalized healthspan strategies… Hit play to discover: What multiomics are and how they can be used to optimize health. What to do when blood tests keep coming back normal despite ongoing symptoms. How pharmacogenomics can predict what a medication actually does for you. The benefits of simulating future health before problems develop. What cellular drift is and how to detect it early. You can connect with Dr. Kekic at Futurome.com, Instagram, LinkedIn, and Youtube!